A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer

Overview of attention for article published in Frontiers in oncology, August 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 38 publications that cite this research output.

38

The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.

Thérapies dans la méningite carcinomateuse du cancer du poumon, du sein et le mélanome : revue systématique de la littérature

Article in Pratique Neurologique - FMC (May 2024)

Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review

Article in Frontiers in Oncology (April 2024)

Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial

Article in ESMO Open (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.